BMI View: Finland’s healthcare system has suffered from a lack of cooperation between primary
healthcare and specialised medical care in recent years. Although the Finnish healthcare system is
undergoing reforms, it will be a while before such changes have an impact, especially considering the weak
state of the economy. In the long term, an aging population and high per capita spending will drive demand
for high-value medicines and quality medical services. However, we believe the associated rising costs will
keep the healthcare and pharmaceutical sectors a target for government cost-containment measures.
Headline Expenditure Projections
? Pharmaceuticals: EUR2.94bn (USD3.23bn) in 2015 to EUR3.03bn (USD3.24bn) in 2016;+3.1% in
local currency terms and +0.3% in US dollar terms. Forecast unchanged from last quarter.
? Healthcare: EUR19.63bn (USD21.59bn) in 2015 to EUR20.42bn (USD21.85bn) in 2016; +4.0% in local
currency terms and +1.2% in US dollar terms. Forecast unchanged from last quarter.

Table of Contents

BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Finland 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Finland 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2012-2020) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Finland 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Finland 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Finland 2012-2020) 22
OTC Medicine Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Finland 2012-2020) 24
Pharmaceutical Trade Forecast 25
Table: Pharmaceutical Trade Data And Forecasts (Finland 2014-2020) 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Finland 2014-2020) 26
Industry Risk/Reward Index 27
Western Europe Risk/Reward Index 27
Finland Risk/Reward Index 32
Rewards 32
Risks 32
Regulatory Review 34
Intellectual Property Issues 35
Pricing Regime 35
Reimbursement Regime 38
Market Overview 40
Healthcare Sector 41
Table: Healthcare Resources (Finland 2010-2015) 44
Table: Healthcare Personnel (Finland 2010-2015) 45
Table: Healthcare Activity (Finland 2010-2015) 45
Research And Development 45
Clinical Trials 46
Epidemiology 47
Competitive Landscape 51
Research-Based Industry 51
Table: Multinational Market Activity 52
Table: PIF Members 54
Pharmaceutical Distribution & Retail Sector 54
Demographic Forecast 55
Table: Population Headline Indicators (Finland 1990-2025) 56
Table: Key Population Ratios (Finland 1990-2025) 56
Table: Urban/Rural Population & Life Expectancy (Finland 1990-2025) 57
Table: Population By Age Group (Finland 1990-2025) 57
Table: Population By Age Group % (Finland 1990-2025) 58
Glossary 60
Methodology 62
Pharmaceutical Expenditure Forecast Model 62
Healthcare Expenditure Forecast Model 62
Notes On Methodology 63
Risk/Reward Index Methodology 64
Index Overview 65
Table: Pharmaceutical Risk/Reward Index Indicators 65
Indicator Weightings 66

List of Tables

Table: Headline Pharmaceuticals & Healthcare Forecasts (Finland 2014-2020)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Finland 2012-2020)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2012-2020)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Finland 2012-2020)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Finland 2012-2020)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Finland 2012-2020)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Finland 2012-2020)
Table: Pharmaceutical Trade Data And Forecasts (Finland 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Finland 2014-2020)
Table: Healthcare Resources (Finland 2010-2015)
Table: Healthcare Personnel (Finland 2010-2015)
Table: Healthcare Activity (Finland 2010-2015)
Table: Multinational Market Activity
Table: PIF Members
Table: Population Headline Indicators (Finland 1990-2025)
Table: Key Population Ratios (Finland 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Finland 1990-2025)
Table: Population By Age Group (Finland 1990-2025)
Table: Population By Age Group % (Finland 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators